Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Kala Pharmaceuticals ( (KALA) ).
Mark S. Blumenkranz, M.D. has abruptly resigned from his positions on the Board of Directors, Audit Committee, and Nominating and Corporate Governance Committee of KALA BIO, Inc., effective immediately. His departure is noteworthy for not being linked to any disputes or disagreements with the company’s operations, policies, or practices.
See more data about KALA stock on TipRanks’ Stock Analysis page.